Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.62 |
| ▸ | XIAP | P98170 | 1/20 | 0.62 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.62 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.57 |
| ▸ | LAP3 | P28838 | 7/20 | 0.56 |
| ▸ | ANPEP | P15144 | 2/20 | 0.56 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.56 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.56 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.56 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 2/20 | 0.55 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | CPA1 | P15085 | 1/20 | 0.48 |
| ▸ | CPA3 | P15088 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2201323 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL650855 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL244193 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7415433 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL3841332 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL2029167 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7698421 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7436847 | 1.00 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL8951308 | 0.98 | ALPI (0.60) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL1309497 | 0.98 | ALPI (0.60) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606830-B2 | Protected antibody-drug and aptamer-drug conjugates | KOSAK KENNETH MICHAEL (US) | 2026-04-21 | — | — | US | disclosed |
| CN-113004252-A | Aryl imidazole derivative and application thereof | 江苏先声药业有限公司 | 2021-06-22 | — | — | CN | disclosed |
| EP-1600457-B1 | PEPTIDE DERIVATIVES HAVING BETA-SECRETASE INHIBITORY ACTIVITY | KISO YOSHIAKI (JP) | 2013-02-20 | — | — | EP | disclosed |
| US-7312188-B2 | Peptide derivatives having β-secretase inhibitory activity | KISO YOSHIAKI | 2007-12-25 | — | — | US | disclosed |
| US-7307184-B2 | Processes for preparing oxazolidinone derivatives of β-hydroxyethlamine compounds and for preparing β-hydroxyethlamine compounds | KANEKA CORPORATION (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20070004637-A1 | Peptide derivatives having beta-secretase inhibitory activity | KISO YOSHIAKI | 2007-01-04 | — | — | US | disclosed |
| US-20060135784-A1 | PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES | KANEKA CORPORATION | 2006-06-22 | — | — | US | disclosed |
| US-7057066-B2 | Process for producing 3-amino-2-hydroxypropionic acid derivatives | KANEKA CORPORATION (JP) | 2006-06-06 | — | — | US | disclosed |
| EP-1600457-A1 | PEPTIDE DERIVATIVES HAVING BETA-SECRETASE INHIBITORY ACTIVITY | Kiso, Yoshiaki (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-6806384-B2 | VIA TREATING N-CARBAMATE-PROTECTED BETA-AMINOEPOXIDE WITH ACID FORMING 5-HYDROXYMETHYL-2-OXAZOLIDINONE, THEN OXIDIZING IN 2,2,6,6-TETRAMETHYL-1-PIPERIDINYLOXY AND HYPOCHLORITE FORMING 4-BENZYL-2-OXO-5-OXAZOLIDINECARBOXYLIC ACID; CRYSTALLIZATION | AJINOMOTO CO., INC. (JP) | 2004-10-19 | — | — | US | disclosed |
| EP-1300391-A1 | PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES | KANEKA CORPORATION (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-20020151722-A1 | Production method of beta-amino-alpha-hydroxycarboxylic acid | AJINOMOTO CO. INC (JP) | 2002-10-17 | — | — | US | disclosed |
| US-6329502-B1 | VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) | JAPAN ENERGY CORPORATION (JP) | 2001-12-11 | — | — | US | disclosed |
| US-6313094-B1 | COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | JAPAN ENERGY CORPORATION (JP) | 2001-11-06 | — | — | US | disclosed |
| US-6271238-B1 | USEFUL IN TREATING AND PREVENTING DISEASES INVOLVING CHYMOTRYPSIN TYPE PROTEASES WHICH ARE RELATED TO ASTHMA, ALLERGY, INFLAMMATIONS, RHEUMATISM, HYPERTENSION, HEART FAILURE, MYOCARDIAL INFARCTION, AND CARDIAC HYPERTROPHY | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2001-08-07 | — | — | US | disclosed |
| EP-0936216-A1 | NOVEL ACETAMIDE DERIVATIVES AND PROTEASE INHIBITORS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1999-08-18 | — | — | EP | disclosed |
| US-5541290-A | OLIGOPEPTIDE CONTAINING ALPHA-KETOAMIDE GROUP, TREATMENT OF ALZHEIMER*S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS | CORTEX PHARMACEUTICALS, INC. | 1996-07-30 | — | — | US | disclosed |
| US-4668769-A | Oxa- and azahomocyclostatine polypeptides | PFIZER INC. | 1987-05-26 | — | — | US | disclosed |
| EP-0211580-A2 | Renin inhibiting polypeptides and intermediates therefor | PFIZER INC. (US) | 1987-02-25 | — | — | EP | disclosed |
| US-4599198-A | Intermediates in polypeptide synthesis | PFIZER INC. (US) | 1986-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151722-A1 | Production method of beta-amino-alpha-hydroxycarboxylic acid | HAO2, HAAO, DAO | ALPI 401/4885PKM 3444/4885PTGS1 61/4885 |
| US-12606830-B2 | Protected antibody-drug and aptamer-drug conjugates | PABPC1, PABPC4, ABCG2 | ALPI 3844/4885PKM 2293/4885PTGS1 2629/4885 |
| US-20060135784-A1 | PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES | AASDHPPT, HPD, HAAO | ALPI 2544/4885PKM 945/4885PTGS1 599/4885 |
| US-20070004637-A1 | Peptide derivatives having beta-secretase inhibitory activity | BACE1, BACE2, APP | ALPI 1496/4885PKM 4158/4885PTGS1 2317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.